Li Huiping
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Multicenter Clinical Study of Apatinib Mesylate Combined With Doctor's Choice for Advanced Breast Cancer (NCT06339281) | Li Huiping | 2024-05-01 |
Track Li Huiping automatically
Every clearance here is in the API, with alerts when new ones post.